Biomea Fusion, Inc. announced that the FDA has lifted the clinical hold on its diabetes treatment BMF-219, allowing trials for Type 1 and Type 2 diabetes to proceed.
AI Assistant
BIOMEA FUSION INC
2024
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.